Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €bn | 8.1 | 11.4 | 8.4 | 10.6 | 9.1 | 9.0 | 9.5 | 9.3 |
| Operating profit | €bn | 0.71 | 0.52 | ||||||
| Net profit | €bn | 0.45 | 0.87 | 0.46 | 2.14 | 0.25 | -1.08 | -1.27 | 0.96 |
| EPS reported | € | -4.17 | -4.82 | ||||||
| Operating cashflow per share | € | 5.35 | 7.28 | ||||||
| Capex per share | € | 2.95 | 4.22 | ||||||
| FCF per share | € | 2.41 | 3.06 | ||||||
| Free cash flow | €bn | 0.62 | 0.76 | ||||||
| Net debt | €bn | 3.30 | 4.46 | ||||||
| Book value equity | €bn | 18.2 | 17.8 | ||||||
| Book value per share | € | 70.36 | 71.25 | ||||||
| Number of shares | m | 259.3 | 250.2 | ||||||
| DPS (TTM paid) | € | 2.50 | 2.50 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.98 | 1.44 | ||||||
| P/S LTM | x | 1.97 | 2.69 | ||||||
| P/FCF LTM | x | 28.57 | 33.47 | ||||||
| EV/EBITDA LTM | x | 5.64 | 14.53 | ||||||
| EV/Sales LTM | x | 2.40 | 3.16 | ||||||
| Earnings Yield LTM | % | -6.06% | -4.91% | ||||||
| FCF Yield | % | 3.50% | 2.99% | ||||||
| Quality | |||||||||
| ROE | % | -5.93% | -7.06% | ||||||
| ROIC | % | 2.08% | 1.20% | ||||||
| Operating margin | % | 7.87% | 5.50% | ||||||
| Gross margin | % | 39.07% | 41.94% | ||||||
| FCF/Sales | % | 6.91% | 8.03% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -0.22% | -26.83% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -38.46% | -13.22% | ||||||
| Operating Profit Growth | % | +6.60% | -55.97% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 4.03% | 2.41% | ||||||
| Dividend Growth | % | 0.00% | 0.00% | ||||||
| Payout Ratio | % | -66.40% | -66.42% | ||||||
| FCF/Debt | x | 0.11 | 0.11 | ||||||
| Net Debt/EBITDA | x | 2.41 | 2.18 | ||||||
| EBIT/Net interest | x | 4.23 | 3.28 | ||||||
| Net debt/market cap | % | 18.49% | 17.42% | ||||||
| Net debt/Equity | x | 0.18 | 0.25 | ||||||
| Gross debt/equity | x | 0.31 | 0.38 | ||||||
ETFs that hold dsm-firmenich
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| iShares SMIM ETF (CH) | CSSMIM.SW | 1 | 7.17% |
| iShares STOXX Europe 600 Food & Beverage UCITS ETF (DE) | EXH3.DE | 6 | 4.01% |
Funds with dsm-firmenich among their ten largest holdings, largest fund first.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
dsm-firmenich AG (DSFIR.AS)
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| iShares SMIM ETF (CH) | CSSMIM.SW | 1 | 7.17% |
| iShares STOXX Europe 600 Food & Beverage UCITS ETF (DE) | EXH3.DE | 6 | 4.01% |
Funds with dsm-firmenich among their ten largest holdings, largest fund first.
Based on consensus from external analysts. Not Kvantra's opinion.
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free